UBS Group’s Spruce Biosciences, Inc. Common Stock SPRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-116,464
| Closed | -$33.8K | – | 9639 |
|
|
2025
Q1 | $33.8K | Buy |
116,464
+30,419
| +35% | +$8.82K | ﹤0.01% | 6567 |
|
|
2024
Q4 | $36.1K | Buy |
86,045
+86,032
| +661,785% | +$36.1K | ﹤0.01% | 6277 |
|
|
2024
Q3 | $6 | Sell |
13
-131,910
| -100% | -$60.9K | ﹤0.01% | 8165 |
|
|
2024
Q2 | $68.3K | Buy |
131,923
+116,109
| +734% | +$60.1K | ﹤0.01% | 5304 |
|
|
2024
Q1 | $12.4K | Buy |
15,814
+15,329
| +3,161% | +$12K | ﹤0.01% | 5966 |
|
|
2023
Q4 | $1.42K | Buy |
485
+472
| +3,631% | +$1.38K | ﹤0.01% | 7095 |
|
|
2023
Q3 | $29 | Hold |
13
| – | – | ﹤0.01% | 7935 |
|
|
2023
Q2 | $28 | Sell |
13
-947
| -99% | -$2.04K | ﹤0.01% | 7576 |
|
|
2023
Q1 | $2.12K | Sell |
960
-4,684
| -83% | -$10.4K | ﹤0.01% | 7474 |
|
|
2022
Q4 | $6.21K | Sell |
5,644
-1,868
| -25% | -$2.06K | ﹤0.01% | 7871 |
|
|
2022
Q3 | $10K | Buy |
7,512
+1,664
| +28% | +$2.22K | ﹤0.01% | 7361 |
|
|
2022
Q2 | $10K | Buy |
5,848
+1,940
| +50% | +$3.32K | ﹤0.01% | 6979 |
|
|
2022
Q1 | $8K | Sell |
3,908
-1,441
| -27% | -$2.95K | ﹤0.01% | 7659 |
|
|
2021
Q4 | $24K | Buy |
+5,349
| New | +$24K | ﹤0.01% | 6534 |
|
|
2021
Q1 | – | Sell |
-4,750
| Closed | -$115K | – | 8301 |
|
|
2020
Q4 | $115K | Buy |
+4,750
| New | +$115K | ﹤0.01% | 4618 |
|